No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial
Isabelle Demeestere(Université Libre de Bruxelles), Yvon Englert(Erasmus Hospital), Alain Kentos(Université Libre de Bruxelles), Pierre Zachée(Erasmus Hospital), Julie Dechène(Erasmus Hospital), Olivier Casasnovas, Viviane De Maertelaer(Université Libre de Bruxelles), Dominique Bron, Pauline Brice(Hôpital Saint-Louis), Fedro A. Peccatori(European Institute of Oncology), Éric Van Den Neste(Erasmus Hospital), Jehan Dupuis(Inserm)
Cited by 241
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Comparison of Computed Density and Macroscopic Morphometry in Pulmonary Emphysema
|American Journal of Respiratory and Critical Care Medicine|1995|884
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
|Journal of Clinical Oncology|1997|706
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Comparison of Computed Density and Microscopic Morphometry in Pulmonary Emphysema
|American Journal of Respiratory and Critical Care Medicine|1996|536